Literature DB >> 9377891

Effect of mechanical ventilation strategy on dissemination of intratracheally instilled Escherichia coli in dogs.

A Nahum1, J Hoyt, L Schmitz, J Moody, R Shapiro, J J Marini.   

Abstract

OBJECTIVE: To test the effect of different mechanical ventilation strategies on dissemination of intratracheally instilled Escherichia coli in dogs and to determine the extent and distribution of lung damage.
DESIGN: Prospective, randomized study.
SETTING: Experimental animal laboratory.
SUBJECTS: Eighteen anesthetized and paralyzed dogs.
INTERVENTIONS: We studied the effect of three ventilatory strategies based on two variables: transpulmonary pressure and positive end-expiratory pressure (PEEP). Group 1 animals (n = 6) were ventilated with a PEEP of 3 cm H2O and a tidal volume of 15 mL/kg, which generated an end-inspiratory transpulmonary pressure of < or = 15 cm H2O. In group 2(n = 6), tidal volume was adjusted to generate a transpulmonary pressure of 35 cm H2O and PEEP was set to 3 cm H2O. In group 3(n = 6), tidal volume was also adjusted to yield a transpulmonary pressure of 35 cm H2O but PEEP was set to 10 cm H2O. In each group, we instilled approximately 10(8) colony-forming units of E. coli into the trachea of the dogs and ventilated them with the chosen tidal volume and PEEP for 6 hrs afterward.
MEASUREMENTS AND MAIN RESULTS: We measured the pressure-volume relationship (pressure-volume curve) of the respiratory system before and 6 hrs after bacterial instillation. We obtained blood cultures before and 0.5, 1,2,3,4,5, and 6 hrs after bacterial instillation. After 6 hrs, the lungs were removed for histologic (histologic score) and gravimetric (wet-to-dry weight ratio, WW/DW) analysis. During the experiment 0, 5, and 1 dogs developed positive blood cultures in groups 1, 2, and 3, respectively. The number of dogs that developed bacteremia in group 2 was significantly greater than in the other two groups (p < .05). In group 1, pressure-volume curves demonstrated a lower inflection point which was greater than the end-inspiratory transpulmonary pressure suggesting that low transpulmonary pressure/low PEEP strategy ventilated aerated regions without expanding atelectatic areas. In group 2, pressure-volume curves demonstrated both a lower inflection point and an upper deflection point which were spanned by the tidal volume, suggesting that high transpulmonary pressure/low PEEP strategy might have caused both overdistention and cyclic closure and reopening. In group 3, pressure-volume curves demonstrated only a upper deflection point which was less than the maximal alveolar tidal pressure. At the end of the experimental protocol, group 2 manifested the most lung injury as assessed by gravimetric and histologic indices of lung injury. WW/DW of group 2(13.1 +/- 1.0 (SD); p < .05) was greater than groups 1 and 3(7.5 +/- 1.2 and 8.6 +/- 1.0, respectively). Similarly, the overall weighted histologic injury score for group 2 (1.19 +/- 0.26; p < .02) was greater than for groups 1 and 3 (0.82 +/- 0.20 and 0.88 +/- 0.22, respectively). For groups 2 and 3, the overall weighted histologic injury scores of the dependent regions were greater than the nondependent regions (p < .004).
CONCLUSIONS: We conclude that the ventilatory strategy most likely to overdistend the lungs while allowing repetitive opening and closure of alveoli (group 2) facilitated bacterial translocation from the alveoli to the bloodstream and increased lung injury, as determined by histologic and gravimetric analysis. PEEP ameliorated these effects, despite lung overdistention, but increased histologic and gravimetric indices of lung injury in dependent as compared with the nondependent regions.

Entities:  

Mesh:

Year:  1997        PMID: 9377891     DOI: 10.1097/00003246-199710000-00026

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  45 in total

Review 1.  Ventilator-associated systemic inflammation in acute lung injury.

Authors:  C Putensen; H Wrigge
Journal:  Intensive Care Med       Date:  2000-10       Impact factor: 17.440

Review 2.  The pulmonary physician in critical care * 7: ventilator induced lung injury.

Authors:  T Whitehead; A S Slutsky
Journal:  Thorax       Date:  2002-07       Impact factor: 9.139

Review 3.  Permissive hypercapnia--role in protective lung ventilatory strategies.

Authors:  John G Laffey; Donall O'Croinin; Paul McLoughlin; Brian P Kavanagh
Journal:  Intensive Care Med       Date:  2004-01-14       Impact factor: 17.440

4.  Is the ventilator responsible for lung and systemic inflammation?

Authors:  Jérôme Pugin
Journal:  Intensive Care Med       Date:  2002-07       Impact factor: 17.440

5.  Challenges of mechanical ventilation in unilateral pneumonia: is PEEP the answer?

Authors:  Alain F Broccard
Journal:  Intensive Care Med       Date:  2004-02-27       Impact factor: 17.440

Review 6.  Cellular stress failure in ventilator-injured lungs.

Authors:  Nicholas E Vlahakis; Rolf D Hubmayr
Journal:  Am J Respir Crit Care Med       Date:  2005-02-01       Impact factor: 21.405

7.  Open up the lung, but smooth and gentle, please!

Authors:  Thomas Bein; Enrico Calzia
Journal:  Intensive Care Med       Date:  2005-09-22       Impact factor: 17.440

Review 8.  [Recruitment maneuvers for patients with lung failure. When, how, whether or not?].

Authors:  J Hinz; O Moerer; M Quintel
Journal:  Anaesthesist       Date:  2005-11       Impact factor: 1.041

Review 9.  Ventilator-induced lung injury: from the bench to the bedside.

Authors:  Lorraine N Tremblay; Arthur S Slutsky
Journal:  Intensive Care Med       Date:  2005-10-18       Impact factor: 17.440

10.  Outcome value of Clara cell protein in serum of patients with acute respiratory distress syndrome.

Authors:  Olivier Lesur; Stephan Langevin; Yves Berthiaume; Martin Légaré; Yoanna Skrobik; Jean-François Bellemare; Bruno Lévy; Yvan Fortier; Francois Lauzier; Gina Bravo; Marc Nickmilder; Eric Rousseau; Alfred Bernard
Journal:  Intensive Care Med       Date:  2006-06-23       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.